Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astera Labs (ALAB) Asset Writedowns and Impairment (2023 - 2024)

Astera Labs (ALAB) has disclosed Asset Writedowns and Impairment for 2 consecutive years, with -$783000.0 as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Asset Writedowns and Impairment fell 557.89% year-over-year to -$783000.0, compared with a TTM value of $168000.0 through Dec 2024, down 98.38%, and an annual FY2024 reading of $168000.0, down 98.38% over the prior year.
  • Asset Writedowns and Impairment was -$783000.0 for Q4 2024 at Astera Labs, down from -$542000.0 in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $9.7 million in Q1 2023 and bottomed at -$783000.0 in Q4 2024.